Luminari CRO Expands Strategic Growth Team with Addition of Dr. Anna Rodecki and Jeffrey Scott Yablon
Summary
Luminari CRO added Dr. Anna Rodecki and Jeffrey Scott Yablon to its business development and strategic advisory team. The company says the hires strengthen its growth efforts and support life sciences clients with clinical development, operational efficiency, and AI-enabled clinical and regulatory intelligence. Dr. Rodecki brings experience in clinical strategy, operations, and commercialization readiness, while Yablon brings global leadership across CROs, biotech, pharma, and technology-enabled clinical development. The appointments reinforce Luminari CRO’s focus on helping sponsors accelerate development and improve decision-making.
Classifications
industries
HealthTech
applications
Data Management
AskAI Classifications
Labels
SaaS
Artificial Intelligence Software
Clinical Trial Software
Linked Companies
Luminari CRO
up to $1M